Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

MSK-Mediated Phosphorylation of Histone H3 Ser28 Couples MAPK Signalling with Early Gene Induction and Cardiac Hypertrophy.

Emma L Robinson | Faye M Drawnel | Saher Mehdi | Caroline R Archer | Wei Liu | Hanneke Okkenhaug | Kanar Alkass | Jan Magnus Aronsen | Chandan K Nagaraju | Ivar Sjaastad | Karin R Sipido | Olaf Bergmann | J Simon C Arthur | Xin Wang | H Llewelyn Roderick
Cells | 2022

Heart failure is a leading cause of death that develops subsequent to deleterious hypertrophic cardiac remodelling. MAPK pathways play a key role in coordinating the induction of gene expression during hypertrophy. Induction of the immediate early gene (IEG) response including activator protein 1 (AP-1) complex factors is a necessary and early event in this process. How MAPK and IEG expression are coupled during cardiac hypertrophy is not resolved. Here, in vitro, in rodent models and in human samples, we demonstrate that MAPK-stimulated IEG induction depends on the mitogen and stress-activated protein kinase (MSK) and its phosphorylation of histone H3 at serine 28 (pH3S28). pH3S28 in IEG promoters in turn recruits Brg1, a BAF60 ATP-dependent chromatin remodelling complex component, initiating gene expression. Without MSK activity and IEG induction, the hypertrophic response is suppressed. These studies provide new mechanistic insights into the role of MAPK pathways in signalling to the epigenome and regulation of gene expression during cardiac hypertrophy.

Pubmed ID: 35203255

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: British Heart Foundation, United Kingdom
    Id: PG/07/040/2289
  • Agency: Research Foundation - Flanders,
    Id: G0C6419N
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/19/53/34499
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/17/31/32988
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/19/39/34447
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/14/70/31039
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/09/052/27833
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/14/71/31063
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BBS/E/B/000C0400-4
  • Agency: Research Foundation - Flanders,
    Id: 1524317N
  • Agency: Research Foundation - Flanders,
    Id: 90663
  • Agency: British Heart Foundation, United Kingdom
    Id: PG/12/76/29852

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


WI (tool)

RRID:RGD_13508588

Rattus norvegicus with name WI from RGD.

View all literature mentions

HEK293 (tool)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions